Pain News and Research

Latest Pain News and Research

Study reveals spinal manipulation therapy reduces severity of pain in many patients

The lessening of pain sensitivity achieved with spinal manipulation therapy (SMT) occurs as a result of the treatment and not as much from a placebo effect caused by the expectation of receiving SMT, according to a study published in The Journal of Pain.

27 Feb 2014

New Gamma Knife stereotactic radiosurgery reduces severe facial pain caused by nerve disorder

Research by Beaumont Health System radiation oncologists and neurosurgeons found that symptoms of trigeminal neuralgia, or TN, a nerve disorder causing severe facial pain, were reduced in those treated with Gamma Knife stereotactic radiosurgery.

27 Feb 2014

Anika Therapeutics receives marketing approval from FDA for MONOVISC injection

Anika Therapeutics, Inc. today announced it has received marketing approval for MONOVISC from the U.S. Food and Drug Administration. MONOVISC is a single injection supplement to synovial fluid of the osteoarthritic joint, used to treat pain and improve joint mobility in patients suffering from osteoarthritis (OA) of the knee.

26 Feb 2014

Just who's exempt from the individual mandate, and how will the IRS enforce it?

One of the most debated parts of the health care law is the requirement that most Americans buy insurance starting this year. … But it's not clear that the IRS will deploy much in the way of resources to aggressively search for individuals who don't get coverage this first year (Adams, 2/24).

26 Feb 2014

FDA approves KALYDECO for people with cystic fibrosis

Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced the U.S. Food and Drug Administration (FDA) approved a supplemental New Drug Application (sNDA) for KALYDECOTM (ivacaftor) for people with cystic fibrosis (CF) ages 6 and older who have one of eight additional mutations in the cystic fibrosis transmembrane conductance regulator (CFTR) gene. KALYDECO was first approved in January 2012 for people with CF ages 6 and older who have at least one copy of the G551D mutation.

26 Feb 2014

Nurses in emergency care must be trained to recognise symptoms of meningococcal septicaemia

Nurses working in emergency care environments must be trained to recognise the atypical signs and symptoms of meningococcal septicaemia.

26 Feb 2014

Regeneron receives FDA acceptance for EYLEA injection for treatment of macular edema

Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that the U.S. Food and Drug Administration (FDA) has accepted for standard review the Company's supplemental Biologics License Application (sBLA) for EYLEA® (aflibercept) Injection for the treatment of Macular Edema following Branch Retinal Vein Occlusion (BRVO).

26 Feb 2014

New way to potentially block chronic pain affecting osteoarthritis sufferers

Researchers from the Arthritis Research UK Pain Centre at The University of Nottingham have discovered a new way to potentially block the chronic and often debilitating pain affecting osteoarthritis sufferers.

26 Feb 2014

Children of women who used acetaminophen during pregnancy appear to be at higher risk for ADHD

Children of women who used the pain reliever acetaminophen (paracetamol) during pregnancy appear to be at higher risk for attention-deficit/hyperactivity disorder (ADHD)-like behavioral problems and hyperkinetic disorders.

26 Feb 2014

Scripps Green Hospital first to implant world's smallest implantable cardiac monitoring device

Scripps Green Hospital has become the first hospital in the United States to implant the world's smallest implantable cardiac monitoring device. Scripps Clinic cardiologist John Rogers, M.D., successfully completed the first implant of the Reveal LINQ- Insertable Cardiac Monitor (ICM) in 71-year-old San Diego resident Chuck Beal on Saturday.

From Medtronic 26 Feb 2014

New blood test can detect heart attacks hours faster than current gold-standard blood test

A new blood test can detect heart attacks hours faster than the current gold-standard blood test, according to a study led by Loyola University Chicago Stritch School of Medicine researchers.

26 Feb 2014

Music in health care can improve quality of life for older people

Using music and singing in health care can improve quality of life for older people by easing pain, anxiety and depression.

26 Feb 2014

Sinus and Allergy Center receives $8.4M NIH grant to help advance development of new treatments

The Northwestern Medicine- Sinus and Allergy Center has received a grant for more than $8.4 million from the National Institutes of Health's (NIH) National Institute of Allergy and Infectious Diseases (NIAID) to help advance the understanding of chronic rhinosinusitis (CRS) and the development of new methods for its treatment over the next five years.

26 Feb 2014

Restless sleep predicts widespread pain in older adults

Non-restorative sleep appears to be a key factor associated with the likelihood of older adults developing widespread pain, study findings reveal.

25 Feb 2014

First Edition: February 25, 2014

Today's headlines include stories exploring the political dynamics governors face regarding the health law's Medicaid expansion.

25 Feb 2014

Experts find that chances of heart or stroke attack doubles after partner's death

Experts studying the impact of bereavement on people's health have found that the chances of a heart or stroke attack doubles after a partner's death.

25 Feb 2014

Opiate use alters activity of specific protein needed for normal functioning of brain's reward center

Identifying the specific pathways that promote opioid addiction, pain relief, and tolerance are crucial for developing more effective and less dangerous analgesics, as well as developing new treatments for addiction.

25 Feb 2014

FDA approves Iroko Pharmaceuticals’ TIVORBEX capsules

Iroko Pharmaceuticals, LLC, a global specialty pharmaceutical company dedicated to advancing the science of analgesia, today announced that the U.S. Food and Drug Administration (FDA) has approved TIVORBEX™ (indomethacin) capsules, a nonsteroidal anti-inflammatory drug (NSAID), at 20 mg and 40 mg doses for the treatment of mild to moderate acute pain in adults.

25 Feb 2014

Greatbatch announces results for fourth quarter and full-year ended 2014

Greatbatch, Inc., today announced results for its fourth quarter and full-year ended January 3, 2014 highlighted by 5% constant currency organic revenue growth for the full year 2013; 12% year over year improvement in adjusted operating income; and 19% improvement in adjusted diluted EPS over 2012.

25 Feb 2014

Enzalutamide shows added benefit in prostate cancer patients without visceral metastases

Enzalutamide (trade name: Xtandi) has been approved since June 2013 for men with metastatic prostate cancer in whom the commonly used hormone blockade is no longer effective and who have already been treated with the cytostatic drug docetaxel.

25 Feb 2014

Pain News and Research

Latest Pain News and Research

Study reveals spinal manipulation therapy reduces severity of pain in many patients

New Gamma Knife stereotactic radiosurgery reduces severe facial pain caused by nerve disorder

Anika Therapeutics receives marketing approval from FDA for MONOVISC injection

Just who's exempt from the individual mandate, and how will the IRS enforce it?

FDA approves KALYDECO for people with cystic fibrosis

Nurses in emergency care must be trained to recognise symptoms of meningococcal septicaemia

Regeneron receives FDA acceptance for EYLEA injection for treatment of macular edema

New way to potentially block chronic pain affecting osteoarthritis sufferers

Children of women who used acetaminophen during pregnancy appear to be at higher risk for ADHD

Scripps Green Hospital first to implant world's smallest implantable cardiac monitoring device

New blood test can detect heart attacks hours faster than current gold-standard blood test

Music in health care can improve quality of life for older people

Sinus and Allergy Center receives $8.4M NIH grant to help advance development of new treatments

Restless sleep predicts widespread pain in older adults

First Edition: February 25, 2014

Experts find that chances of heart or stroke attack doubles after partner's death

Opiate use alters activity of specific protein needed for normal functioning of brain's reward center

FDA approves Iroko Pharmaceuticals’ TIVORBEX capsules

Greatbatch announces results for fourth quarter and full-year ended 2014

Enzalutamide shows added benefit in prostate cancer patients without visceral metastases

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Pain News and Research

Latest Pain News and Research

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Newsletters you may be interested in